Nike Stock: Buy, Hold, or Sell? (My Final Verdict) | NKE Stock Deep Dive Part 5
Summary
Parkev discusses Nike's recent stock performance and future outlook, concluding that it is not a buying opportunity. He attributes the stock's significant decline, over 46% year-to-date, primarily to new management guidance. Parkev highlights that Nike's management informed Wall Street analysts that revenue is expected to decline in the high single digits (7-9%) for the upcoming fiscal year 2027, a stark contrast to Nike's historical high single-digit growth. This negative outlook is projected to continue into 2028.
Parkev notes that his previous optimism for Nike when the stock hit around $40 was based on an expectation of a low single-digit revenue decline for FY2027, with improvement anticipated over the year. However, the updated guidance, suggesting a worsening trend through FY2027 and beyond, was much more severe than his forecast. Additionally, operating income is projected to fall even more sharply, by 15-20%.
Parkev has consistently lowered his fair value estimate for Nike due to the company repeatedly underperforming his expectations. His current fair value for Nike is $26.60, significantly below the current market price of $35. While Nike's forward P/E ratio of 20 appears historically cheap, Parkev cautions that this valuation is justified by ongoing sales declines, falling operational margins, increasing trade barriers, a deteriorating consumer environment, and a weakened competitive position. Parkev states he has no interest in buying Nike at the current $35 price level and would only reconsider if the stock price dropped closer to $25 or if he observed tangible improvements in the company's performance.
Mentioned Stocks
Reasoning: Parkev states that Nike is not a buying opportunity at its current price of $35. He revised his assessment downwards significantly after Nike's management announced an expected revenue decline in the high single digits (7-9%) for fiscal year 2027, with the negative trend continuing into 2028. This outlook is much worse than his previous expectation of a low single-digit decline with an improvement over the year. Additionally, operating income is projected to fall by 15-20%. Parkev has lowered his fair value estimate to $26.60. While the stock trades at a historically low P/E of 20, Parkev believes this is justified by persistent sales declines, falling margins, worsening consumer conditions, and weakened competitive standing. Parkev explicitly states he would only be interested in buying if the stock price falls to around $25, or if he sees a clear improvement in the company's performance.